For the Inventor, By the Inventor

Enter assignee name

Sunnyvale, CA, United States of America

Cepheid Corporation

USPTO Granted Patents = 192

% Expired Patents = 13.0

CIPO Patents = 14

EPO Patents = 54

Trademarks = 16

Forward Citations = 6,363

Loading Chart...

Loading Chart...

123 inventors (with patents filed for the assignee):

Ronald G Chang (68 out of 77 patents)

Douglas Bryan Dority (45 out of 57 patents)

William A McMillan (43 out of 63 patents)

4. Farzad Pourahmadi (29 out of 35 patents)

5. Kurt Edward Petersen (29 out of 71 patents)

6. Lee Allan Christel (24 out of 30 patents)

7. M Allen Northrup (21 out of 46 patents)

8. Steven M Montgomery (21 out of 30 patents)

9. Gregory E Mote (19 out of 19 patents)

10. Jesus Ching (17 out of 57 patents)

11. Gregory T A Kovacs (17 out of 34 patents)

12. Reuel Van Atta (16 out of 17 patents)

13. Alexander A Gall (14 out of 47 patents)

14. Sergey G Lokhov (13 out of 24 patents)

15. Doug Dority (12 out of 12 patents)

Core Competencies:

Molecular Diagnostic Assay

DNA Methylation

Nucleic Acid Amplification

Cancer Detection

Sample Processing

Polymerase Inhibitors

Fluorescent Dyes

Remote Monitoring

Thermal Control

RNA Extraction

Biosecurity Screening

Encoderless Motor

192 patents: Sort by Forward Citations

1. 12762680 - Transfer learning methods and models facilitating defect detection (2026-10-13),

2. 12678787 - Diagnostic detection chip devices and methods of manufacture and assembly (2026-07-14),

3. 12651985 - Encoderless motor with improved quantization and methods of use and calibration (2026-06-09),

4. 12637269 - Film seal assembly and single lid assay cartridge and associated methods (2026-05-26),

5. 12631678 - LED characterization and compensation methods and systems (2026-05-19),

6. 12629680 - Universal assay cartridge and methods of use (2026-05-19),

7. 12555070 - RFID Kanban system and methods of use (2026-02-17),

8. 12539510 - INTEGRATED PURIFICATION AND MEASUREMENT OF DNA METHYLATION AND CO-MEASUREMENT OF MUTATIONS AND/OR MRNA EXPRESSION LEVELS IN AN AUTOMATED REACTION CARTRIDGE (2026-02-03),

9. 12428388 - Nonionic polyether surfactants (2025-09-30),

10. 12410483 - Methods of detecting bladder cancer (2025-09-09),

11. 12385045 - Thermostable polymerase inhibitor compositions and methods (2025-08-12),

12. 12365891 - Methods and compositions for nucleic acid isolation (2025-07-22),

13. 12321183 - Thermal control device and methods utilizing temperature distribution modeling (2025-06-03),

14. 12281358 - Honeycomb tube (2025-04-21),

15. 12280379 - Molecular diagnostic assay system (2025-04-21),

Company Overview

Cepheid Corporation, headquartered in Sunnyvale, California, specializes in molecular diagnostics, focusing on the development and manufacturing of innovative diagnostic assays. The company is renowned for its expertise in nucleic acid amplification technologies, which are pivotal in cancer detection and other critical health applications. Cepheid's core technologies encompass DNA methylation analysis, sample processing, and the use of polymerase inhibitors and fluorescent dyes, enabling rapid and accurate diagnostic solutions for healthcare providers worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

192 Patents

#29 in Sunnyvale, CA

#466 in California

#2,143 in US

#4,386 in the World

Sunnyvale, CA, United States of America

Cepheid Corporation

Forward Citations = 6,363

123 inventors:

Ronald G Chang (68 out of 77 patents)

Douglas Bryan Dority (45 out of 57 patents)

William A McMillan (43 out of 63 patents)

4. Farzad Pourahmadi (29 out of 35 patents)

5. Kurt Edward Petersen (29 out of 71 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cepheid Corporation. Retrieved from https://idiyas.com/company/cepheid

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…